Richard Xie, PhD

Senior Health Economist

Name: RA Capital
Price range: $

Richard Xie is a Senior Health Economist at RA Capital Management. Richard’s primary responsibilitiy is to communicate our industry’s and portfolio companies’ value proposition to payors, policymakers, and society through comprehensive cost-effectiveness analyses and GCEA method development. Prior to RA Capital, Richard served as Director of Research at the Innovation and Value Initiative (IVI), a non-profit research organization dedicated to advancing methods and practices of health technology assessment. At IVI, he managed a portfolio of research projects and worked with leading researchers and multi-stakeholder advisory committees. These research projects tested and operationalized novel approaches in stakeholder engagement, patient preference, economic modeling, and health equity. Before IVI, he was a consultant at the Analysis Group, assisting clients in the pharmaceutical industry with their value demonstration efforts at product launches. Richard holds both a BA and a MA from New York University, and a PhD in Economics from the University of Southern California.

Department: Healthcare
Degree: PhD
Joined: 2023
University / College: New York University, University of Southern California